Compound Radar

Albemarle Corporation (ALB) Stock Analysis

Price $129.57
Market cap $15.29B
Next earnings Nov 4, 2026
Entry status Wait

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

45
45/100 Speculative
  • Financial Health 30
  • Profitability 40
  • Business Quality 50
  • Balance Sheet 65
  • Cash Flow 70

Why this rating?

Health 45/100 — Speculative

Strongest Cash Flow 70/100
Softest Financial Health 30/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

Albemarle Corporation (ALB) is a Specialty Chemicals company in the Basic Materials sector. Compound Radar rates Albemarle Corporation 45/100 (Speculative) due to solid business quality, strong revenue growth, and elevated leverage.

Investment profile

  • Quality Moderate
  • Growth Strong
  • Balance Sheet Stretched
  • Valuation Attractive

Financial highlights

Valuation

  • P/E 479.89
  • Forward P/E 11.47
  • PEG 0.79
  • EV/Revenue 3.01

Profitability

  • Revenue Growth 31.1%
  • Gross Margin 24.0%
  • Operating Margin 27.7%
  • Net Margin 3.8%
  • ROE 2.6%

Financial strength

  • Cash $1.63B
  • Debt $2.00B
  • Net Cash $-367.25M
  • Free Cash Flow $692.47M
  • Current Ratio 2.09

Similar companies

Peers in Specialty Chemicals, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Specialty Chemicals →

FAQ

How Compound Radar scores and tracks Albemarle Corporation (ALB).

View Methodology & FAQ →